EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access

Propofol-associated Hypertriglyceridemia: Development and Multicenter Validation of a Machine-Learning-Based Prediction Tool

Jiawen Deng iD, Kiyan Heybati iD, Keshav Poudel, Guozhen Xie, Eric Zuberi iD, Vinaya Simha, Hemang Yadav iD

Journal of Intensive Care Medicine · 2025

DOI: 10.1177/08850666251342559 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Jiawen Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Propofol, Hypertriglyceridemia, Machine Learning, Hypnotics and Sedatives. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Mayo Clinic Critical Care Research Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To develop and validate an explainable machine learning (ML) tool to help clinicians predict the risk of propofol-associated hypertriglyceridemia in critically ill patients receiving propofol sedation.

Methods

Patients from 11 intensive care units (ICUs) across five Mayo Clinic hospitals were included if they met the following criteria: a) ≥ 18 years of age, b) received propofol infusion while on invasive mechanical ventilation for ≥24 h, and c) had a triglyceride level measured. The primary outcome was hypertriglyceridemia (triglyceride >400 mg/dL) onset within 10 days of propofol initiation. Both COVID-inclusive and COVID-independent modeling pipelines were developed to ensure applicability post-pandemic. Decision thresholds were chosen to maintain model sensitivity >80%. Nested leave-one-site-out cross-validation (LOSO-CV) was used to externally evaluate pipeline performance. Model explainability was assessed using permutation importance and SHapley Additive exPlanations (SHAP).

Results

Among 3922 included patients, 769 (19.6%) developed propofol-associated hypertriglyceridemia, and 879 (22.4%) had COVID-19 at ICU admission. During nested LOSO-CV, the COVID-inclusive pipeline achieved an average AUC-ROC of 0.71 (95% confidence interval [CI] 0.70–0.72), while the COVID-independent pipeline achieved an average AUC-ROC of 0.69 (95% CI 0.68–0.70). Age, initial propofol dose, and BMI were the top three most important features in both models.

Conclusion

We developed an explainable ML-based tool with acceptable predictive performance for assessing the risk of propofol-associated hypertriglyceridemia in ICU patients. This tool can aid clinicians in identifying at-risk patients to guide triglyceride monitoring and optimize sedative selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolHypertriglyceridemiaMachine LearningHypnotics and SedativesHumansFemaleMaleMiddle AgedAgedIntensive Care UnitsCOVID-19Respiration, ArtificialCritical IllnessAdult

Stichwörter der Autor:innen

critical carehypertriglyceridemiamachine-learningmechanical ventilationpropofolsedation

Substanzen

PropofolHypnotics and Sedatives

Autor:innen und Institutionen

  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Jiawen Deng, Kiyan Heybati, Eric Zuberi, Hemang Yadav

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Mayo Clinic Critical Care Research Committee

Zitieren

APA

Deng, J., Heybati, K., Poudel, K., Xie, G., Zuberi, E., Simha, V., & Yadav, H. (2025). Propofol-associated Hypertriglyceridemia: Development and Multicenter Validation of a Machine-Learning-Based Prediction Tool. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666251342559

Vancouver

Deng J, Heybati K, Poudel K, Xie G, Zuberi E, Simha V, et al. Propofol-associated Hypertriglyceridemia: Development and Multicenter Validation of a Machine-Learning-Based Prediction Tool. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666251342559

BibTeX
@article{Deng2025,
  author = {Deng, Jiawen and Heybati, Kiyan and Poudel, Keshav and Xie, Guozhen and Zuberi, Eric and Simha, Vinaya and Yadav, Hemang},
  title = {Propofol-associated Hypertriglyceridemia: Development and Multicenter Validation of a Machine-Learning-Based Prediction Tool},
  journal = {Journal of Intensive Care Medicine},
  year = {2025},
  doi = {10.1177/08850666251342559}
}
Kostenlos starten →